Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotype-specific inhibition of the vascular smooth muscle cell cycle by high glucose treatment.

Diabetologia - 1 Apr 2007

Zheng X-L, Yuan S-G, Peng D-Q

Abstract excerpt

AIMS/HYPOTHESIS: Diabetes accelerates the development of atherosclerosis, which critically involves the proliferation of vascular smooth muscle cells (SMCs). However, how high glucose treatment regulates SMC proliferation is controversial. Considering the established SMC heterogeneity, we hypothesised that glucose treatment may have distinct effects on proliferation of the various phenotypic SMCs. MATERIALS AND...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Enzyme Inhibitors
Share to Epithelial Cells
Share to Glucose

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Muscle, Smooth, Vascular

Share to Myocytes, Smooth Muscle

Share to Phorbol Esters

Share to Protein Kinase C

Share to Rats, Sprague-Dawley

Source

Identifiers

PMID: 17334654
DOI: 10.1007/s00125-006-0543-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotype-specific inhibition of the vascular smooth muscle cell cycle by high glucose treatment.PMID 17334654Read ↗

Regulation of smooth muscle cells in development and vascular disease: current therapeutic strategies.Semantic proximity Read ↗

Type 2 diabetes impairs venous, but not arterial smooth muscle cell function: possible role of differential RhoA activity.Semantic proximity Read ↗

Calcineurin-mediated pathway involved in the differentiated phenotype of smooth muscle cells.Semantic proximity Read ↗

Epidermal growth factor induction of phenotype-dependent cell cycle arrest in vascular smooth muscle cells is through the mitogen-activated protein kinase pathway.Semantic proximity Read ↗

[Phenotypic modulation of vascular smooth muscle cells in diabetes mellitus and intervention of traditional Chinese medicines].Semantic proximity Read ↗

Metabolic control of smooth muscle cell phenotype switching in atherosclerosisSemantic proximity Read ↗

Control of cell proliferation in atherosclerosis: insights from animal models and human studiesSemantic proximity Read ↗

MicroRNA-146b-3p regulates the dysfunction of vascular smooth muscle cells via repressing phosphoinositide-3 kinase catalytic subunit gamma.Semantic proximity Read ↗

Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function.Semantic proximity Read ↗

Phenotype modulation in primary cultures of aortic smooth muscle cells from streptozotocin-diabetic rats.Semantic proximity Read ↗

γ-Secretase inhibitor DAPT attenuates intimal hyperplasia of vein grafts by inhibition of Notch1 signaling.Semantic proximity Read ↗

Aberrant phenotype in human endothelial cells of diabetic origin: implications for saphenous vein graft failure?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.